
Wendy A. Woodward MD MD, PhD
Breast Cancer
Professor; Department Chair Breast Radiation Oncology; Executive Director MD Anderson Inflammatory Breast Cancer Clinic and Research Program
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Woodward is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2001 - 2005
- Albert Einstein Medical CenterInternship, Transitional Year, 2000 - 2001
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2000
- Thomas Jefferson UniversityPh.D., Biochemistry and Molecular Biology, 2000
- Mount Holyoke CollegeBA, Chemistry, Cum Laude, 1993
Certifications & Licensure
- FL State Medical License 2021 - Present
- GA State Medical License 2023 - 2026
- OK State Medical License 2020 - 2026
- TX State Medical License 2005 - 2026
- AL State Medical License 2023 - 2025
- AZ State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- American Board of Radiology Radiation Oncology
- Join now to see all
Awards, Honors, & Recognition
- Robert M. Chamberlain Distinguished Mentor Award The University of Texas MD Anderson Cancer Center, 2014
- Honorable Mention, 5th Annual Awards for Excellence in Training and Mentorship in Cancer Prevention The University of Texas MD Anderson Cancer Center, 2013
- Finalist, Robert M. Chamberlain Distinguished Mentor Award MD Anderson Postdoctoral Association, 2011, 2013
- Join now to see all
Clinical Trials
- Xeloda (Capecitabine) and External Beam Radiation Start of enrollment: 2009 Jun 05
- Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer Start of enrollment: 2012 Jan 01
- Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter Start of enrollment: 2014 Jul 31
Publications & Presentations
PubMed
- Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic Score.Filipa Lynce, Samuel M Niman, Megumi Kai, Sean Ryan Ma, Elizabeth Troll
Journal of the National Cancer Institute. 2025-03-31 - 1 citationsAdding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial.Jay P Reddy, Alexander D Sherry, Bryan Fellman, Suyu Liu, Tharakeswara Bathala
International Journal of Radiation Oncology, Biology, Physics. 2025-03-15 - Cholesterol efflux protein, ABCA1, supports anti-cancer functions of myeloid immune cells.Shruti V Bendre, Yu Wang, Basel Hajyousif, Rajendra K C, Shounak G Bhogale
Biorxiv. 2025-02-19
Journal Articles
- Rates of Immune Cell Infiltration in Patients with Triple-Negative Breast Cancer by Molecular SubtypeWendy A Woodward, Naoto T Ueno, Savitri Krishnamurthy, Bora Lim, PLoS One
- Association of Transforming Growth Factor Β Polymorphism C−509T with Radiation-Induced Fibrosis Among Patients with Early-Stage Breast CancerA Secondary Analysis of a ...Karen E Hoffman, Elizabeth S Bloom, Pamela J Schlembach, Thomas A Buchholz, Benjamin D Smith, Wendy A Woodward, Welela Tereffe, Simona F Shaitelman, Michael C Stauder, JAMA
- Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast CancerMichael C Stauder, Anthony Lucci, Wendy A Woodward, Bora Lim, Naoto T Ueno, ScienceDirect
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Phase II Study of Panitumumab, Nab-paclitaxel, and Carboplatin Followed by FEC Neoadjuvant Chemotherapy for Patients with Primary HER-2 Negative Inflammatory Breast Ca...Matsuda N, Alvarez RH, Krishnamurthy S, Willey JS, Wang X, Lim B, Parker CA, Marx A, Babiera G, Booser DJ, Murray JL, Arun B, Brewster AM, Reuben JM, Woodward WA, Lucc..., Proceedings ASCO Annual Meeting, 1/1/2015
- EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancerWoodward WA, Huo L, Li J, Sneige N, Gonzalez-Angulo AM, Debeb BG, Chang C, Hung M, Valero V, Ueno NT, Int J Radiat Oncol Biol Phys, Proceedings of ASTRO, 1/1/2012
- Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumorsWoodward WA, 7th Annual Uterine Cancer Biology Symposium, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/19/2011
- Join now to see all
Lectures
- Predictors and prognosticators for precision radiotherapyHouston, TX - 1/26/2015
- Opportunities for Innovation in Radiation OncologyNashville, TN - 1/23/2015
- Breast Cancer SummitPuerto Rico - 1/13/2015
- Join now to see all
Press Mentions
- Inflammatory Breast Cancer: 14 Things to KnowApril 17th, 2024
- More Women with Breast Cancer Could Skip Harsh Radiation, Study SaysFebruary 16th, 2023
- More Women with Breast Cancer Could Survive Harsher Radiation, Study SaysFebruary 15th, 2023
- Join now to see all
Grant Support
- Deciphering the Mechanism of Lymphovascular Space Invasion Using a Lymphovascularized Bioengineering Breast Stromal PlatformUNIVERSITY OF TEXAS AT AUSTIN2024–2029
- Deciphering the Mechanism of Lymphovascular Space Invasion Using a Lymphovascularized Bioengineering Breast Stromal PlatformUNIVERSITY OF TEXAS AT AUSTIN2024–2029
- Human Breast Cancer Stem Cell SurrogatesNational Cancer Institute2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: